title: Lack of effect of methotrexate in budesonide-refractory collagenous colitis.
abstract: BACKGROUND
  In most cases, collagenous colitis can be treated effectively with budesonide. However, some patients develop side effects or have chronic symptoms refractory to budesonide. This paper reports an open case series of patients intolerant or refractory to budesonide who were treated with methotrexate (MTX).
  
  
  METHODS
  Nine patients (seven women) with a median (range) age of 62 (44-77) years were studied. Bowel movements were registered during 1 week prior to baseline and after 6 and 12 weeks' treatment, enabling calculation of the mean bowel movements/day. All patients underwent colonoscopy with biopsies before inclusion to confirm diagnosis. Open treatment with MTX was given 15 mg subcutaneously weekly for 6 weeks and was increased to 25 mg for a further 6 weeks if symptoms were unresponsive to the first 6 weeks' treatment. The endpoint was clinical remission, which was defined as a mean <3 stools/day and mean <1 watery stool/day/week at Week 12. The Short Health Scale was used at baseline and Week 12 to assess health-related quality of life.
  
  
  RESULTS
  Five patients fulfilled the treatment according to the protocol and four patients discontinued the study after 3-6 weeks because of adverse events. No patient achieved clinical remission at Week 12. The mean stool frequency/day at baseline was 6.0 stools/day, thereof 5.4 watery stools/day and after 12 weeks treatment 6.4 stools/day, thereof 5.7 watery/day. No patient appreciated an improvement of health-related quality of life.
  
  
  CONCLUSIONS
  Short-term treatment with MTX had no clinical effect in collagenous colitis patients intolerant or refractory to budesonide. Alternative therapies should be investigated in these patients.
authors.affiliation: Division of Gastroenterology and Hepatology, Department of Clinical and Experimental Medicine, Faculty of Health science, Linköping University, Linköping.
authors.forename: Andreas
authors.initials: A
authors.lastname: Münch
authors.forename: Johan
authors.initials: J
authors.lastname: Bohr
authors.forename: Lina
authors.initials: L
authors.lastname: Vigren
authors.forename: Curt
authors.initials: C
authors.lastname: Tysk
authors.forename: Magnus
authors.initials: M
authors.lastname: Ström
keywords: MTX; Short Health Scale; diarrhea; health-related quality of life; microscopic colitis; stools
references.citation: Inflamm Bowel Dis. 2009 Dec;15(12):1875-81
references.pmid: 19504614
references.citation: Gastroenterology. 2002 Jan;122(1):20-5
references.pmid: 11781276
references.citation: Gut. 2004 Mar;53(3):346-50
references.pmid: 14960513
references.citation: Histopathology. 2002 Apr;40(4):374-6
references.pmid: 11943023
references.citation: Gut. 2003 Feb;52(2):248-51
references.pmid: 12524408
references.citation: Gut. 2009 Jan;58(1):68-72
references.pmid: 18669576
references.citation: Scand J Gastroenterol. 2006 Oct;41(10):1196-203
references.pmid: 16990205
references.citation: Gut. 2007 Apr;56(4):504-8
references.pmid: 17135309
references.citation: Scand J Gastroenterol. 2011 Nov;46(11):1334-9
references.pmid: 21854096
references.citation: J Gastroenterol Hepatol. 2007 Oct;22(10):1589-93
references.pmid: 17845686
references.citation: Aliment Pharmacol Ther. 2005 Dec;22(11-12):1115-9
references.pmid: 16305725
references.citation: Gastroenterology. 2001 May;120(6):1483-4
references.pmid: 11313319
references.citation: Am J Gastroenterol. 2009 Jan;104(1):235-41; quiz 234, 242
references.pmid: 19098875
references.citation: Gastroenterology. 2002 Oct;123(4):978-84
references.pmid: 12360457
references.citation: Gastroenterology. 2008 Nov;135(5):1510-6
references.pmid: 18926826